TPW
CVS icon

Transatlantique Private Wealth’s CVS Health CVS Stock Holding History

Transatlantique Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$555K Sell
6,991
-274
-4% -$21.6K 0.17% 141
2025
Q3 		$548K Sell
7,265
-464
-6% -$31.8K 0.18% 143
2025
Q2 		$533K Sell
7,729
-2,195
-22% -$144K 0.2% 143
2025
Q1 		$672K Sell
9,924
-1,549
-14% -$92.7K 0.27% 115
2024
Q4 		$515K Sell
11,473
-198
-2% -$11.1K 0.2% 144
2024
Q3 		$734K Buy
11,671
+363
+3% +$21.2K 0.28% 109
2024
Q2 		$648K Sell
11,308
-10,706
-49% -$670K 0.26% 111
2024
Q1 		$1.76M Buy
22,014
+153
+0.7% +$11.7K 0.77% 31
2023
Q4 		$1.73M Buy
21,861
+1,419
+7% +$101K 0.8% 29
2023
Q3 		$1.43M Buy
20,442
+80
+0.4% +$5.67K 0.76% 32
2023
Q2 		$1.41M Buy
20,362
+4,514
+28% +$321K 0.73% 35
2023
Q1 		$1.18M Buy
15,848
+1,137
+8% +$95.3K 0.65% 44
2022
Q4 		$1.37M Buy
14,711
+345
+2% +$33.3K 0.82% 29
2022
Q3 		$1.37M Buy
14,366
+498
+4% +$49.3K 0.92% 25
2022
Q2 		$1.28M Buy
+13,868
New +$1.35M 0.89% 26

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Transatlantique Private Wealth's CVS Position: Q4 2025 in Review

Transatlantique Private Wealth reduced its CVS Health (CVS) stake by 3.8% in Q4 2025, selling an estimated $21.6K and leaving 6,991 shares worth $555K. The position accounts for 0.17% of the portfolio, ranked #141.

Transatlantique Private Wealth first reported a position in CVS in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.76M in Q1 2024. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Transatlantique Private Wealth held 6,991 shares of CVS Health worth $555K as of Q4 2025.
  • Transatlantique Private Wealth sold 274 CVS Health shares in Q4 2025, an estimated $21.6K.
  • CVS Health made up 0.17% of Transatlantique Private Wealth's portfolio in Q4 2025, its #141 holding.
  • Transatlantique Private Wealth first reported a position in CVS Health in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's CVS Health position peaked at $1.76M in Q1 2024.
  • 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.